Raphael Pharmaceutical RAPH
OTC RAPH
$1.51 +0.00 (+0.00%)
At close: Oct 19, 2026 · 4:00 PM EDT

Raphael Pharmaceutical (RAPH) EBITDA (2023)

Updated

Raphael Pharmaceutical (RAPH) recorded EBITDA of -$419,000 in Q2 2023.

Analysis

Raphael Pharmaceutical (RAPH) EBITDA (2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA (Qtr)
1 Eli Lilly 1,134.50 Bn 1,103.09 Bn 19.71 Bn 12.29 Bn
2 Johnson & Johnson 616.20 Bn 534.73 Bn 17.26 Bn 9.10 Bn
3 AbbVie 500.82 Bn 473.93 Bn 12.70 Bn 8.33 Bn
4 Merck 367.31 Bn 321.69 Bn 12.21 Bn 999.00 Mn
5 Novartis Ag 297.77 Bn 261.76 Bn 11.24 Bn -
6 Astrazeneca 261.35 Bn 235.04 Bn 12.86 Bn 5.09 Bn
7 Amgen 235.40 Bn 190.80 Bn 7.24 Bn 4.63 Bn
8 Gilead Sciences 190.59 Bn 164.79 Bn 6.22 Bn -9.70 Bn
9 Pfizer 169.39 Bn 116.04 Bn 10.94 Bn 5.89 Bn
10 Raphael Pharmaceutical 30.47 Mn 30.40 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 -419,000.00
Mar 31, 2023 -257,000.00
API Access

Raphael Pharmaceutical EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda&ticker=RAPH&period=max&api_key=YOUR_API_KEY